The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of PD-1/ PD-L1 and statin combination therapy on gastrointestinal toxicity related to immune checkpoint inhibitors and on survival.
 
Yinghong Wang
Consulting or Advisory Role - AzurRx BioPharma; Tillotts Pharma
 
Jay Sanjay Shah
No Relationships to Disclose
 
Andres Caleb Urias Rivera
No Relationships to Disclose
 
Antony Mathew
No Relationships to Disclose
 
Anusha Thomas
No Relationships to Disclose
 
Mehmet Altan
Consulting or Advisory Role - AstraZeneca; BMS; GlaxoSmithKline
Speakers' Bureau - Nektar
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Shattuck Labs (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - Hengenix
 
Dan Zhao
Consulting or Advisory Role - Affinit-T
Research Funding - CARsgen Therapeutics (Inst); Mirati Therapeutics (Inst)